Molecular Cancer, 2025 Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease Fidelle M., Chen H., Montégut L. et al. Olink Explore 3072/384OncologyPatient StratificationPlasma | | | | |
BMJ Open, 2025 Prospective association of the triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio with anxiety risk in a community-based cohort: a UK Biobank study Ren H., Zhao T., Lv Z. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
npj Vaccines, 2025 A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination Cha I., Yamada Y., Kim D. et al. Olink Target 48 MouseInfectious DiseasesPathophysiologyMouse Cell Culture Supernatant | | | | |
Nature Communications, 2025 Deriving consensus sepsis clusters via goal-directed subgroup identification in multi-omics study Zhang Z., Chen L., Shen H. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
BMC Pulmonary Medicine, 2025 Potential drug targets for chronic obstructive pulmonary disease in the plasma proteome identified through Mendelian randomization Jia Q., Xiao J., Zhang W. et al. Olink Target 96Respiratory DiseasesPathophysiologyPlasma | | | | |
Ecotoxicology and Environmental Safety, 2025 Smoking elevating osteoarthritis risk: Insights from genetics, blood DNA methylations and proteome profiles Ling D., Jiang Z., Zhou H. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
BMC Oral Health, 2025 Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients Eriksson L., Larsson A., Eriksson M. et al. Olink Target 96Surgical ComplicationsTechnical EvaluationPlasmaSaliva | | | | |
Blood Cancer Journal, 2025 Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance Hsu J., Yadav U., Garapati K. et al. Olink Explore 3072/384OncologyPathophysiologyBone Marrow Plasma | | | | |
PLOS One, 2025 A plasma-based protein signature association with all-cause mortality Koziar N., Whetton A., Geifman N. Olink Explore 3072/384Wider Proteomics StudiesPatient StratificationPlasma | | | | |
European Journal of Medical Research, 2025 Proteomics identifies complement protein signatures in patients with primary biliary cholangitis Ma X., Dong H., Han J. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
npj Parkinson's Disease, 2025 The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemic van der Heide A., Kischkel B., Rovers C. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
British Journal of Pharmacology, 2025 UK Biobank: Transforming drug discovery and precision medicine Bešević J., Said S., Nagy R. et al. Olink Explore 3072/384Wider Proteomics StudiesReview/editorialPlasma | | | | |
Experimental and Molecular Pathology, 2025 Persistent renin-angiotensin system and inflammatory dysregulation following COVID-19 impairs ischemic stroke recovery Quek A., Teng O., Park J. et al. Olink Explore 3072/384NeurologyInfectious DiseasesPathophysiologyPlasma | | | | |
Molecular Neurobiology, 2025 Mendelian Randomization Unlocks Stroke Therapeutics: Dioscin Inhibits CD27-Driven Neuroinflammation via Gut Microbiota Modulation Tan H., Li S., Yan H. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Neurocritical Care, 2025 Biomarker Differences in Aneurysmal Subarachnoid Hemorrhage: A Comparative Study of Patients with and Without Delayed CEREBRAL Ischemia Santafé M., Quintana M., Sánchez A. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Molecular Oncology, 2025 Next‐generation proteomics improves lung cancer risk prediction Bhardwaj M., Frick C., Schöttker B. et al. Olink Explore 3072/384Olink Explore HTOncologyPatient StratificationPlasma | | | | |
Metabolism, 2025 Air pollution exacerbates cardiovascular-kidney-metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: A multi-omics and Mendelian Randomization study Wei S., Shu Z., Li X. et al. Olink Explore 3072/384Metabolic DiseasesCVDNephrologyPathophysiologyPlasma | | | | |
Frontiers in Medicine, 2025 Comprehensive proteome profiling of molecular endotypes in Japanese adults with moderate-to-severe atopic dermatitis Serelli-Lee V., Ozeki A., Preuss C. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPatient StratificationSerum | | | | |
Clinical Cancer Research, 2025 Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors Perez K., Horick N., Baginksa J. et al. Olink Target 96OncologyPathophysiologyPlasmaCell Culture Supernatant | | | | |
Brain, Behavior, and Immunity, 2025 Searching for blood biomarkers and treatment targets in Women with fibromyalgia – Protein interaction patterns and anti-satellite glia cell IgG antibodies as promising candidates Ekenstam K., Menezes J., Jakobsson J. et al. Olink Explore 3072/384NeurologyPatient StratificationSerum | | | | |